Brief: TherapeuticsMD And Theramex Announce Approval Of Bijuve Capsules For Hormone Replacement Therapy In UK And Belgium
April 8 (Reuters) - TherapeuticsMD Inc TXMD.O :
* THERAPEUTICSMD AND THERAMEX ANNOUNCE THE APPROVAL OF
BIJUVE®
CAPSULES INDICATED FOR HORMONE REPLACEMENT THERAPY IN THE UNITED
KINGDOM AND UNDER THE TRADE NAME BIJUVA® IN BELGIUM
* THERAPEUTICSMD - THERAMEX EXPECTS APPROVALS FROM OTHER
MAJOR EU
COUNTRIES SHORTLY
Source text for Eikon: ID:nBwbmDrJQa
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TherapeuticsMD
See all newsBrief: TherapeuticsMD Announces First Quarter 2026 Financial Results
TherapeuticsMD swings to Q1 net income as license revenue rises
TherapeuticsMD swings to Q3 profit, license revenue climbs
Brief: TherapeuticsMD Q1 Operating Expenses USD 1.264 Million
Brief: Therapeuticsmd - Files Lawsuit Against Mayne Pharma For Breach Of Contract